Dec 30, 2022
1:4
For every 4 shares held, investors received 1. The price per share adjusted from $0.60 to $0.15.
The split itself did not change the total investment value.
Epigenomics AG (EPGNY) trades on the Other OTC in the Medical - Diagnostics & Research industry.
Epigenomics AG company overviewThe latest split shown was on December 30, 2022. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
This history records 2 reverse splits between December 28, 2020 and December 30, 2022.
Already premium? Sign in